scholarly article | Q13442814 |
P2093 | author name string | Liping Wang | |
Xinhong Zhang | |||
Shuguang Zuo | |||
P2860 | cites work | A scaling normalization method for differential expression analysis of RNA-seq data | Q24628783 |
Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma | Q24632791 | ||
An integrated genomic analysis of human glioblastoma multiforme | Q24648860 | ||
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. | Q27824850 | ||
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data | Q27860819 | ||
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
The somatic genomic landscape of glioblastoma | Q28300185 | ||
CD79B and MYD88 mutations in diffuse large B-cell lymphoma | Q51121788 | ||
Mining TCGA database for genes of prognostic value in glioblastoma microenvironment. | Q54195728 | ||
ß-Elemene inhibits proliferation of human glioblastoma cells and causes cell-cycle G0/G1 arrest via mutually compensatory activation of MKK3 and MKK6. | Q54398698 | ||
Transmission of a TP53 germline mutation from unaffected male carrier associated with pediatric glioblastoma in his child and gestational choriocarcinoma in his female partner. | Q54942730 | ||
Identification of genes inducing resistance to ionizing radiation in human rectal cancer cell lines: re-sensitization of radio-resistant rectal cancer cells through down regulating NDRG1. | Q55154557 | ||
A Review of the Potential Utility of Mycophenolate Mofetil as a Cancer Therapeutic | Q59051193 | ||
Therapeutic targeting of the BCR-associated protein CD79b in a TCR-based approach is hampered by aberrant expression of CD79b | Q64166628 | ||
Ten-year survival in glioblastoma. A systematic review | Q88866300 | ||
Characterization of human type I and type II IMP dehydrogenases | Q28623113 | ||
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma | Q29615604 | ||
Survival in glioblastoma: a review on the impact of treatment modalities. | Q30251810 | ||
Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients | Q30458538 | ||
Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age | Q33378354 | ||
Performance status during and after radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma multiforme | Q33405266 | ||
Human cancers express mutator phenotypes: origin, consequences and targeting | Q33554201 | ||
Treatment and outcomes for glioblastoma in elderly compared with non-elderly patients: a population-based study | Q33611190 | ||
Primary and secondary glioblastomas: from concept to clinical diagnosis | Q34364235 | ||
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors | Q34913026 | ||
Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. | Q35609699 | ||
Factors influencing survival in high-grade gliomas | Q35650045 | ||
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas | Q36236484 | ||
Targeting MKK3 as a novel anticancer strategy: molecular mechanisms and therapeutical implications. | Q36347205 | ||
Glioblastomas with copy number gains in EGFR and RNF139 show increased expressions of carbonic anhydrase genes transformed by ENO1. | Q36713853 | ||
TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes | Q36777326 | ||
Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring. | Q37081252 | ||
Recent advances in p53 research: an interdisciplinary perspective. | Q37273304 | ||
Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas | Q37698352 | ||
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma-a critical review. | Q37926494 | ||
Temozolomide and radiotherapy for newly diagnosed glioblastoma multiforme: a systematic review | Q38170398 | ||
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma | Q38722204 | ||
Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy. | Q38731753 | ||
Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner | Q39090175 | ||
Assessment of the clinical relevance of 17q25.3 copy number and three-dimensional telomere organization in non-small lung cancer patients | Q40259346 | ||
MKK3 as oncotarget | Q42583176 | ||
Analysis of chromosome 17 miRNAs and their importance in medulloblastomas | Q43213773 | ||
IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas | Q43276389 | ||
Radiotherapy for glioblastoma in the elderly. | Q44527062 | ||
Impact of radiotherapy delay on survival in glioblastoma | Q47312999 | ||
Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme. | Q47425171 | ||
Age alone is not a predictor for survival in glioblastoma. | Q48626728 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | edgeR | Q113334690 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | glioblastoma | Q282142 |
P304 | page(s) | 2615 | |
P577 | publication date | 2019-02-22 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastoma | |
P478 | volume | 9 |
Q92024236 | Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma |
Q99546534 | Identification of a cullin5-RING E3 ligase transcriptome signature in glioblastoma multiforme |
Q92798823 | Identification of seven-gene signature for prediction of lung squamous cell carcinoma |
Q97568897 | Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis |
Search more.